Review Article
The Risk of Colon Cancer in Inflammatory Bowel Disease
Ross Jones, Martin Scobey and Jianfeng Cheng*
Division of Gastroenterology, Internal Medicine, UNC School of Medicine Charlotte, Carolinas Medical Center, USA
- *Corresponding Author:
- Jianfeng Cheng
Clinical Assistant Professor of Medicine
UNC School of Medicine Charlotte campus
Division of Gastroenterology
Department of Internal Medicine
Carolinas Medical Center, Charlotte, NC 28203, USA
Tel: 704 355-7470
Fax: 704 355-0770
E-mail: Jianfeng.cheng@carolinashealthcare.org
Received date: December 12, 2013; Accepted date: December 30, 2013; Published date: January 08, 2014
Citation: Jones R, Scobey M, Cheng J (2014) The Risk of Colon Cancer in Inflammatory Bowel Disease. J Gastroint Dig Syst 4:164. doi:10.4172/2161-069X.1000164
Copyright: © 2014 Jones R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Inflammatory Bowel Disease (IBD) involves chronic inflammation in the patient’s digestive track, leading to the development of ulcerative colitis and Crohn’s disease. IBD is painful and debilitating disease that develops into life threatening risk in the long run, particularly colorectal carcinoma (CRC). As per the studies, there are 18% of chances for the IBD to develop into colorectal carcinoma after 30 years. Although IBD is contributing to only 1% of overall Colorectal Cancer cases, the mortality rate is pretty high among the colorectal cancer developed due to IBD. The present article prescribes guidelines for screening and surveillance that minimizes the risks of CRC.
